The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
Rodgers, T., & Rowland, M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20502 · Cited by 946
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
Brian Houston, J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90520-7 · Cited by 925
Rodgers, T., Leahy, D., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20322 · Cited by 776
The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data
Sun, K. (2005) · Chinese New Drugs Journal · Cited by 762
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Predicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability
Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00179-x · Cited by 651
Clearance concepts in pharmacokinetics
Rowland, M., Benet, L. Z., & Graham, G. G. (1973) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059626 · Cited by 649
Poulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
Rostami-Hodjegan, A., & Tucker, G. T. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2173 · Cited by 530
Zhao, P., Zhang, L., Grillo, J. A., Liu, Q., Bullock, J. M., Moon, Y. J., Song, P., Brar, S. S., Madabushi, R., Wu, T. C., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.298 · Cited by 522
Jones, H., Chen, Y., Gibson, C., Heimbach, T., Parrott, N., Peters, S., Snoeys, J., Upreti, V., Zheng, M., & Hall, S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.37 · Cited by 488
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data
Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., & Sugiyama, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00184-2 · Cited by 479
Obach, R. S., Walsky, R. L., & Venkatakrishnan, K. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012633 · Cited by 460
Population-Based Mechanistic Prediction of Oral Drug Absorption
Jamei, M., Turner, D., Yang, J., Neuhoff, S., Polak, S., Rostami-Hodjegan, A., & Tucker, G. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9099-y · Cited by 452
Poulin, P., & Theil, F. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<16::aid-jps3>3.0.co;2-e · Cited by 424
Shah, D. K., & Betts, A. M. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9232-2 · Cited by 422
Jamei, M., Dickinson, G. L., & Rostami-Hodjegan, A. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.53 · Cited by 368
FACTORS AFFECTING DRUG METABOLISM
Gillette, J. R. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb46890.x · Cited by 348
Berezhkovskiy, L. M. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20073 · Cited by 296
Mayhew, B. S., Jones, D. R., & Hall, S. D. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15182-3 · Cited by 293
Tsamandouras, N., Rostami‐Hodjegan, A., & Aarons, L. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12234 · Cited by 250
Jones, H. M., Barton, H. A., Lai, Y., Bi, Y.-A., Kimoto, E., Kempshall, S., Tate, S. C., El-Kattan, A., Houston, J. B., Galetin, A., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042994 · Cited by 244
Chu, X., Korzekwa, K., Elsby, R., Fenner, K., Galetin, A., Lai, Y., Matsson, P., Moss, A., Nagar, S., Rosania, G. R., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.78 · Cited by 236
Prediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs
Poulin, P., Schoenlein, K., & Theil, F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<436::aid-jps1002>3.0.co;2-p · Cited by 213
Zhao, P., Rowland, M., & Huang, S.-M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.68 · Cited by 212
Fahmi, O. A., Hurst, S., Plowchalk, D., Cook, J., Guo, F., Youdim, K., Dickins, M., Phipps, A., Darekar, A., Hyland, R., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026252 · Cited by 212
The utility of modeling and simulation in drug development and regulatory review
Huang, S.-M., Abernethy, D. R., Wang, Y., Zhao, P., & Zineh, I. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23570 · Cited by 206
Fahmi, O. A., Maurer, T. S., Kish, M., Cardenas, E., Boldt, S., & Nettleton, D. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018663 · Cited by 204
Modelling and PBPK Simulation in Drug Discovery
Jones, H. M., Gardner, I. B., & Watson, K. J. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9088-1 · Cited by 202
Applications of minimal physiologically-based pharmacokinetic models
Cao, Y., & Jusko, W. J. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9280-2 · Cited by 202
PREDICTION OF CYTOCHROME P450 3A INHIBITION BY VERAPAMIL ENANTIOMERS AND THEIR METABOLITES
Wang, Y.-H., Jones, D. R., & Hall, S. D. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.2.259 · Cited by 200
PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals
Bois, F. Y., Jamei, M., & Clewell, H. J. (2010) · Toxicology · doi:10.1016/j.tox.2010.06.007 · Cited by 194
Regulatory Experience With Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials
Leong, R., Vieira, M. L. T., Zhao, P., Mulugeta, Y., Lee, C. S., Huang, S.-M., & Burckart, G. J. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.19 · Cited by 187
Baxter, L. T., Zhu, H. J., Mackensen, D. G., Butler, W. F., & Jain, R. K. (1995) · PubMed · Cited by 180
Sjögren, E., Westergren, J., Grant, I., Hanisch, G., Lindfors, L., Lennernäs, H., Abrahamsson, B., & Tannergren, C. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.019 · Cited by 168
Jamei, M., Bajot, F., Neuhoff, S., Barter, Z., Yang, J., Rostami-Hodjegan, A., & Rowland-Yeo, K. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0097-y · Cited by 163
Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies
Cao, Y., Balthasar, J. P., & Jusko, W. J. (2013) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-013-9332-2 · Cited by 161
Shono, Y., Jantratid, E., Janssen, N., Kesisoglou, F., Mao, Y., Vertzoni, M., Reppas, C., & Dressman, J. B. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.05.009 · Cited by 158
Abduljalil, K., Cain, T., Humphries, H., & Rostami‐Hodjegan, A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058099 · Cited by 152
The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review
Huang, S.-M., & Rowland, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.320 · Cited by 150 · cited 1×
“As a result, the label states that “a post-marketing requirement for the effect of cabazitaxel on the pharmacokinetics of a sensitive CYP3A4 substrate is therefore not necessary” (Huang and Rowland, 2012; Huang et al., 2013; CDER, 2010).”
Gertz, M., Cartwright, C. M., Hobbs, M. J., Kenworthy, K. E., Rowland, M., Houston, J. B., & Galetin, A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0918-y · Cited by 148
Tornio, A., Filppula, A. M., Kailari, O., Neuvonen, M., Nyrönen, T., Tapaninen, T., Neuvonen, P. J., Niemi, M., & Backman, J. T. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.141 · Cited by 144
Ferl, G. Z., Wu, A. M., & DiStefano, J. J. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-7410-3 · Cited by 142
Characterization and application of physiologically based pharmacokinetic models in risk assessment
Buist, H. E. (2010) · TNO Repository · Cited by 137
Gaohua, L., Abduljalil, K., Jamei, M., Johnson, T. N., & Rostami‐Hodjegan, A. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04363.x · Cited by 133
Lumping of Whole-Body Physiologically Based Pharmacokinetic Models
Nestorov, I. A., Aarons, L. J., Arundel, P. A., & Rowland, M. (1998) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1023/a:1023272707390 · Cited by 132
Varma, M. V. S., Lai, Y., Feng, B., Litchfield, J., Goosen, T. C., & Bergman, A. J. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0792-7 · Cited by 131
Thiel, C., Schneckener, S., Krauß, M., Ghallab, A., Hofmann, U., Kanacher, T., Zellmer, S., Gebhardt, R., Hengstler, J. G., & Kuepfer, L. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24214 · Cited by 119
Ke, A. B., Nallani, S. C., Zhao, P., Rostami‐Hodjegan, A., & Unadkat, J. D. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12207 · Cited by 117
Parrott, N. J., Davies, B., Hoffmann, G., Koerner, A., Lavé, T., Prinssen, E. P. M., Theogaraj, E., & Singer, T. (2011) · Clinical Pharmacokinetics · doi:10.2165/11592640-000000000-00000 · Cited by 116
Chen, Y., Jin, J. Y., Mukadam, S., Malhi, V., & Kenny, J. R. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1769 · Cited by 115
Harwood, M. D., Neuhoff, S., Carlson, G., Warhurst, G., & Rostami‐Hodjegan, A. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1810 · Cited by 111
Lombardo, F., Waters, N. J., Argikar, U. A., Dennehy, M. K., Zhan, J., Gunduz, M., Harriman, S. P., Berellini, G., Liric Rajlic, I., & Obach, R. S. (2013) · The Journal of Clinical Pharmacology · doi:10.1177/0091270012440282 · Cited by 106
Wang, Y.-H. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032177 · Cited by 103
Rajoli, R. K. R., Back, D. J., Rannard, S. P., Meyers, C. L. F., Flexner, C. W., Owen, A., & Siccardi, M. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0227-1 · Cited by 100
Di, L., Feng, B., Goosen, T. C., Lai, Y., Steyn, S. J., Varma, M. V. S., & Obach, R. S. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054031 · Cited by 100
Meyer, M. C., Schneckener, S., Ludewig, B., Kuepfer, L., & Lippert, J. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.043174 · Cited by 100
Zhao, P., Vieira, M. D. L. T., Grillo, J. A., Song, P., Wu, T., Zheng, J., Arya, V., Berglund, E. G., Atkinson, A. J., Sugiyama, Y., et al. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011415528 · Cited by 98
Zhang, X., Quinney, S. K., Gorski, J. C., Jones, D. R., & Hall, S. D. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026658 · Cited by 97
Ke, A., Nallani, S., Zhao, P., Rostami‐Hodjegan, A., & Unadkat, J. D. (2012) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.2 · Cited by 93
THE ROLES OF TRANSPORTERS AND ENZYMES IN HEPATIC DRUG PROCESSING
Liu, L., & Pang, K. S. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001149 · Cited by 93
Parrott, N. J., Jones, H. M., Paquereau, N., & Lavé, T. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto960308.x · Cited by 93
Maraviroc:in vitroassessment of drug–drug interaction potential
Hyland, R., Dickins, M., Collins, C., Jones, H. M., & Jones, B. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03198.x · Cited by 90
Ke, A. B., Nallani, S. C., Zhao, P., Rostami‐Hodjegan, A., Isoherranen, N., & Unadkat, J. D. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050161 · Cited by 90
Self-citationHsu, V., Vieira, M. D. L. T., Zhao, P., Zhang, L., Zheng, J., Nordmark, A., Berglund, E. G., Giacomini, K. M., & Huang, S. M. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0117-y · Cited by 85
Zhao, P., Ragueneau, I., Zhang, L., Strong, J. M., Reynolds, K. S., Levy, R. H., Thummel, K. E., & Huang, S. M. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008331196 · Cited by 84
Lombardo, F., Waters, N. J., Argikar, U. A., Dennehy, M. K., Zhan, J., Gunduz, M., Harriman, S. P., Berellini, G., Rajlic, I. L., & Obach, R. S. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270012440281 · Cited by 83
Wagner, C., Jantratid, E., Kesisoglou, F., Vertzoni, M., Reppas, C. I., & Dressman, J. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.05.008 · Cited by 81
Xu, L., Chen, Y., Pan, Y., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025494 · Cited by 81
Johnson, T. N., Zhou, D., & Bui, K. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1899 · Cited by 80
Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model
Zhao, J., Cao, Y., & Jusko, W. J. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1703-5 · Cited by 78
Baneyx, G., Parrott, N. J., Meille, C., Iliadis, A., & Lavé, T. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.02.002 · Cited by 78
Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction
Almond, L. M., Yang, J., Jamei, M., Tucker, G. T., & Rostami‐Hodjegan, A. (2009) · Current Drug Metabolism · doi:10.2174/138920009788498978 · Cited by 76
Li, R., Barton, H. A., Yates, P. D., Ghosh, A., Wolford, A. C., Riccardi, K. A., & Maurer, T. S. (2014) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-014-9357-1 · Cited by 75
Dealing with the complex drug–drug interactions: Towards mechanistic models
Varma, M. V. S., Pang, K. S., Isoherranen, N., & Zhao, P. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1934 · Cited by 74
Self-citationPilari, S., & Huisinga, W. (2010) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-010-9165-1 · Cited by 72
Xia, B.-F., Heimbach, T., Gollen, R., Nanavati, C., & He, H. (2013) · AAPS Journal · doi:10.1208/s12248-013-9505-3 · Cited by 72
Neuhoff, S., Yeo, K. R., Barter, Z. E., Jamei, M., Turner, D. B., & Rostami‐Hodjegan, A. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23594 · Cited by 71
Bosgra, S., van de Steeg, E., Vlaming, M. L. H., Verhoeckx, K. C. M., Huisman, M. T., Verwei, M., & Wortelboer, H. M. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.09.007 · Cited by 71
Zane, N. R., & Thakker, D. R. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0181-y · Cited by 70
Varma, M. V. S., Lin, J., Bi, Y., Kimoto, E., & Rodrigues, A. D. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064303 · Cited by 69
Li, G.-F., Wang, K., Chen, R., Zhao, H.-R., Yang, J., & Zheng, Q.-S. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.103 · Cited by 68
Barton, H. A., Lai, Y., Goosen, T. C., Jones, H. M., El-Kattan, A. F., Gosset, J. R., Lin, J., & Varma, M. V. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.759210 · Cited by 68
Fenneteau, F., Poulin, P., & Nekka, F. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21802 · Cited by 66
Fei, Y., Kostewicz, E. S., Sheu, M., & Dressman, J. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.03.001 · Cited by 66
Li, L., Gardner, I. B., Dostálek, M., & Jamei, M. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9640-5 · Cited by 64
Fan, J., Chen, S., Chow, E. C. Y., & Pang, K. S. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328931 · Cited by 63
Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion
Pang, K. S., & Durk, M. R. (2010) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-010-9185-x · Cited by 62
Ballesta, A., Zhou, Q. S., Zhang, X., Lv, H., & Gallo, J. (2014) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2014.9 · Cited by 60
Varma, M. V. S., Lin, J., Bi, Y., Rotter, C. J., Fahmi, O. A., Lam, J. L., El‐Kattan, A. F., Goosen, T. C., & Lai, Y. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050583 · Cited by 60
Damle, B. D., Varma, M. V. S., & Wood, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-11 · Cited by 59
Varma, M. V. S., Scialis, R. J., Lin, J., Bi, Y., Rotter, C. J., Goosen, T. C., & Yang, X. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9614-7 · Cited by 58
Physiologically Based Pharmacokinetic Modeling: From Regulatory Science to Regulatory Policy
Sinha, V. P., Zhao, P., Huang, S. M., & Zineh, I. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.46 · Cited by 58
Kambayashi, A., Blume, H. H., & Dressman, J. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.09.009 · Cited by 58
Sayama, H., Takubo, H., Komura, H., Kogayu, M., & Iwaki, M. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9626-3 · Cited by 57
Neuhoff, S., Yeo, K. R., Barter, Z. E., Jamei, M., Turner, D. B., & Rostami‐Hodjegan, A. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23607 · Cited by 57
Emoto, C., Fukuda, T., Cox, S., Christians, U., & Vinks, A. A. T. M. M. (2013) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.33 · Cited by 56
Lu, G., Abduljalil, K., Jamei, M., Johnson, T. N., Soltani, H., & Rostami‐Hodjegan, A. (2012) · Current Drug Metabolism · doi:10.2174/138920012800840374 · Cited by 56
Djebli, N., Fabre, D., Boulenc, X., Fabre, G., Sultan, E., & Hurbin, F. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062596 · Cited by 56
Heimbach, T., Xia, B., Lin, T., & He, H. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9419-5 · Cited by 55
Cubitt, H. E., Yeo, K. R., Howgate, E. M., Rostami‐Hodjegan, A., & Barter, Z. E. (2011) · Xenobiotica · doi:10.3109/00498254.2011.560294 · Cited by 55
Gérard, C., Stocco, J., Hulin, A., Blanchet, B., Verstuyft, C., Durand, F., Conti, F., Duvoux, C., & Tod, M. (2014) · AAPS Journal · doi:10.1208/s12248-014-9577-8 · Cited by 52
Siccardi, M., Marzolini, C., Seden, K., Almond, L. M., Kirov, A., Khoo, S., Owen, A., & Back, D. J. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0056-7 · Cited by 51
Caldwell, J. C., Evans, M. V., & Krishnan, K. (2012) · Journal of Toxicology · doi:10.1155/2012/852384 · Cited by 51
Chen, Y., Mao, J., & Hop, C. E. C. A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059311 · Cited by 51
Kletting, P., Kull, T. J., Bunjes, D. W., Mahren, B., Luster, M., Reske, S. N., & Glatting, G. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.067546 · Cited by 51
Rekić, D., Röshammar, D., Mukonzo, J., & Ashton, M. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03883.x · Cited by 50
Cho, H., Kim, J.-E., Kim, D., & Yoon, I. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.831439 · Cited by 46
Physiologically Based Pharmacokinetic Prediction of Telmisartan in Human
Li, R., Ghosh, A., Maurer, T. S., Kimoto, E., & Barton, H. A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058461 · Cited by 45
Why We Need Proper PBPK Models to Examine Intestine and Liver Oral Drug Absorption
Chow, E. C. Y., & Pang, K. S. (2012) · Current Drug Metabolism · doi:10.2174/1389200211309010057 · Cited by 45
Vieira, M. L. T., Zhao, P., Berglund, E. G., Reynolds, K. S., Zhang, L., Lesko, L. J., & Sm, H. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.305 · Cited by 44
Brantley, S., Gufford, B., Dua, R., Fediuk, D., Graf, T., Scarlett, Y., Frederick, K. S., Fisher, M., Oberlies, N., & Paine, M. (2014) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.69 · Cited by 44
Patel, N. K., Polak, S., Jamei, M., Rostami‐Hodjegan, A., & Turner, D. B. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.006 · Cited by 44
Cao, Y., & Jusko, W. J. (2014) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-014-9374-0 · Cited by 44
Chetty, M., Mattison, D. R., & Rostami‐Hodjegan, A. (2012) · Current Drug Metabolism · doi:10.2174/138920012800840464 · Cited by 43
Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo
Kaspera, R., Kirby, B. J., Sahele, T., Collier, A. C., Kharasch, E. D., Unadkat, J. D., & Totah, R. A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.020 · Cited by 42
Impact of Physiologically Based Pharmacokinetic Modeling and Simulation in Drug Development
Shardlow, C. E., Generaux, G. T., Patel, A. H., Tai, G., Tran, T. B., & Bloomer, J. C. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052803 · Cited by 42
Gertz, M., Tsamandouras, N., Säll, C., Houston, J. B., & Galetin, A. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1333-3 · Cited by 41
Kudo, T., Hisaka, A., Sugiyama, Y., & Ito, K. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.049460 · Cited by 39
Guo, H., Liu, C., Li, J., Zhang, M., Hu, M., Xu, P., Liu, L., & Liu, X. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23613 · Cited by 38
Péry, A., Brochot, C., Zeman, F., Mombelli, E., Desmots, S., Pavan, M., Fioravanzo, E., & Zaldívar, J. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.03.032 · Cited by 38
Zhao, Y., & Hu, Z. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12533 · Cited by 37
Chetty, M., Li, L., Rose, R. H., Machavaram, K. K., Jamei, M., Rostami‐Hodjegan, A., & Gardner, I. B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00670 · Cited by 37
Zhang, H., Xia, B., Sheng, J., Heimbach, T., Lin, T., He, H., Wang, Y., Novick, S. J., & Comfort, A. R. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0075-1 · Cited by 37
Why We Need Proper PBPK Models to Examine Intestine and Liver Oral Drug Absorption
Chow, E. C. Y., & Pang, K. S. (2012) · Current Drug Metabolism · doi:10.2174/138920013804545124 · Cited by 35
Physiologically based pharmacokinetic (PBPK) modeling: It is here to stay!
Rostami‐Hodjegan, A., Tamai, I., & Pang, K. S. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1776 · Cited by 34
Wu, F. P., Gaohua, L., Zhao, P., Jamei, M., Huang, S. M., Bashaw, E. D., & Lee, S. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1293-z · Cited by 33
Li, J., Guo, H., Liu, C., Zhong, Z., Liu, L., & Liu, X. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0192-8 · Cited by 33
Progress in Simulation Modelling for Pharmacokinetics
Leahy, D. E. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033451961 · Cited by 33
Friedman, E. J., Fraser, I. P., Wang, Y., Bergman, A. J., Li, C., Larson, P., Chodakewitz, J., Wagner, J. A., & Stoch, S. A. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010387141 · Cited by 32
Darwich, A. S., Pade, D., Rowland‐Yeo, K., Jamei, M., Åsberg, A., Christensen, H., Ashcroft, D. M., & Rostami‐Hodjegan, A. (2013) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.23 · Cited by 31
Parrott, N. J., Hainzl, D., Scheubel, E., Krimmer, S., Boetsch, C., Guerini, E., & Martin‐Facklam, M. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9639-y · Cited by 31
Physiologically based pharmacokinetic model of midazolam disposition during pregnancy
Andrew, M. A., Hébert, M. F., & Vicini, P. (2008) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2008.4650448 · Cited by 31
Shi, J., Fraczkiewicz, G., Williams, W. V., & Yeleswaram, S. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.30 · Cited by 30
Challenges of Using In Vitro Data for Modeling P-Glycoprotein Efflux in the Blood-Brain Barrier
Sjöstedt, N., Kortejärvi, H., Kidron, H., Vellonen, K., Urtti, A. O., & Yliperttula, M. L. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1124-2 · Cited by 30
Xia, B., Heimbach, T., Lin, T., Li, S., Zhang, H., Sheng, J., & He, H. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-0018-2 · Cited by 29
Teeguarden, J., Housand, C., Smith, J. N., Hinderliter, P. M., Gunawan, R., & Timchalk, C. A. (2012) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2012.10.007 · Cited by 27
Zhu, L., Zhang, Y., Yang, J.-W., Wang, Y., Zhang, J., Zhao, Y., & Dong, W. (2015) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-015-0271-8 · Cited by 26
Hu, Z.-Y., Edginton, A. N., Laizure, S. C., & Parker, R. B. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0160-3 · Cited by 26
Yeo, K. R., Kenny, J. R., & Rostami‐Hodjegan, A. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1467-3 · Cited by 26
Tools for predicting the PK/PD of therapeutic proteins
Diao, L., & Meibohm, B. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1041917 · Cited by 25
Steere, B. A., Baker, J. A. R., Hall, S. D., & Guo, Y. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061523 · Cited by 24
Dhuria, S. V., Einolf, H. J., Mangold, J. B., Sen, S., Gu, H., Wang, L., & Cameron, S. B. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.79 · Cited by 23
Poulin, P. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24468 · Cited by 23
von Kleist, M., & Huisinga, W. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.12.010 · Cited by 23
Galetin, A. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-758-7_13 · Cited by 22
Ball, K., Bouzom, F., Scherrmann, J., Walther, B., & Declèves, X. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1908 · Cited by 22
Yan, G. Z., Generaux, C., Yoon, M., Goldsmith, R. B., Tidwell, R. R., Hall, J. E., Olson, C. A., M.A., H. J. C. I., Brouwer, K. L. R., & Paine, M. F. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040063 · Cited by 22
Wang, Y., Wang, Z. K., Zuo, Z., Tomlinson, B., Lee, B. T. K., Bolger, M. B., & Chow, M. S. S. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9479-1 · Cited by 20
Edginton, A. N., Ahr, G., Willmann, S., & Staß, H. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00004 · Cited by 19
Gerard, C., Bleyzac, N., Girard, P., Freyer, G., Bertrand, Y., & Tod, M. M. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0252-1 · Cited by 18
Assessment of inter-individual variability in predicted phenytoin clearance
Polasek, T. M., Polak, S., Doogue, M. P., Rostami‐Hodjegan, A., & Miners, J. O. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0703-y · Cited by 18
Wang, J., Xia, S., WeiFang, X., Wang, D., Sai, Y., Liu, L., & Liu, X. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.07.012 · Cited by 18
Wu, C., Sun, L., Sun, J., Yang, Y., Ren, C., Ai, X., Lian, H., & He, Z. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.034 · Cited by 18
A Physiologically Based Pharmacokinetic Model for Clobazam and Stiripentol in Adults and Children
and the CRESim & Epi-CRESim Project Groups, Ogungbenro, K., & Aarons, L. J. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1451-y · Cited by 16
Zhu, L., Yang, J.-W., Zhang, Y., Wang, Y., Zhang, J., Zhao, Y., & Dong, W. (2015) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.19.2.99 · Cited by 15
Brown, J. L., Crison, J. R., & Timmins, P. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.81 · Cited by 15
Have physiologically-based pharmacokinetic models delivered?
Edginton, A. N., & Joshi, G. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.585968 · Cited by 13
Simplification of Complex Physiologically Based Pharmacokinetic Models of Monoclonal Antibodies
Elmeliegy, M. A., Lowe, P. J., & Krzyżański, W. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9591-x · Cited by 10
Vinks, A. A. T. M. M. (2013) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.9 · Cited by 9
Bui, K., Zhou, D., Agbo, F., & Guo, J. P. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.515 · Cited by 8
Turner, D. C., Yin, F., Kindt, J. T., & Zhang, H. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1818 · Cited by 5
Cited by
Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
Kuepfer, L., Niederalt, C., Wendl, T., Schlender, J., Willmann, S., Lippert, J., Block, M., Eissing, T., & Teutonico, D. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12134 · Cited by 425
Workgroup, E. M., Marshall, S., Burghaus, R., Cosson, V, Cheung, S., Chenel, M., DellaPasqua, O., Frey, N., Hamrén, B., Harnisch, L., et al. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12049 · Cited by 373
Singh, A. V., Ansari, M. H. D., Rosenkranz, D., Maharjan, R. S., Kriegel, F. L., Gandhi, K., Kanase, A., Singh, R., Laux, P., & Luch, A. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901862 · Cited by 310
Jamei, M. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0059-9 · Cited by 244
Prantil-Baun, R., Novak, R., Das, D., Somayaji, M. R., Przekwas, A., & Ingber, D. E. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104748 · Cited by 176
Metadata
- Authors
- Sager, J. E., Yu, J., Ragueneau-Majlessi, I., & Isoherranen, N.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 43
- Issue
- 11
- Pages
- 1823-1837
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2103606212
- Cited by
- 518
- References
- 163
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.